Dr. Alexander Demidenko, DO

Dr. Demidenko practices at Long Island Ophthalmology & Eye Surgery, P. C. in Far Rockaway, New York.

Dr. Demidenko's NPI, 1356542591, was assigned on May 29, 2007. Dr. Demidenko graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2003. Dr. Demidenko holds New York license 249146.

Dr. Demidenko's primary practice is Long Island Ophthalmology & Eye Surgery, P. C., at 20-4 Seagirt Blvd, Far Rockaway, NY 11691 in Queens County. The practice phone is (718) 868-8668.

Dr. Demidenko's primary practice is Long Island Ophthalmology & Eye Surgery, P. C. in Far Rockaway, New York. Dmand AI also links Dr. Demidenko to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demidenko practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Demidenko's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Demidenko is board certified in ophthalmology by the AOA Board of Ophthalmology and Otolaryngology. Dr. Demidenko is licensed in New York.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Demidenko treats.

CMS data shows 848 Medicare services from Dr. Demidenko across 7 procedure codes in 2024, for 220 Medicare patients. Medicare paid $50,114 for them. Every service was in an office.

CMS counts 220 Medicare patients who saw Dr. Demidenko in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 90% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Demidenko's median patient age at 72, with 60% women.

In 2024, Dr. Demidenko wrote 2,085 Medicare Part D claims for 355 patients. 68% of them were for generic drugs. CMS names the drug for 1,983 of them, across 27 drugs with 11 or more claims each, at $171,022 in total drug cost. In 2023, CMS named 1,746 claims across 25 drugs.

CMS counts 17 procedures of cataract surgery by Dr. Demidenko, more than 41% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Demidenko, published from 2009 to 2010. The most frequent topics are Eye Enucleation and Iris.

CMS Open Payments shows 29 general payments to Dr. Demidenko from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Shire North American Group Inc paid the most, $167.

Dr. Demidenko graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2003. Dr. Demidenko is a member of AAO and AOA.

Dr. Demidenko is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.